Breakthroughs at Centenary Institute
As a world-leading independent Medical Research Institute for over 30 years we have had significant breakthroughs and impacted medical research in the areas of cancer, inflammation and cardiovascular.
2018
Improved the diagnosis rate of a potentially deadly heart condition by up to 20 per cent.
Discovered a potential new pathway for cancer therapies.
Liver Enzymes in Metabolism and Inflammation Program
Boosted the human body’s fight against melanoma by uncovering a new pathway in the body.
Skin Imaging and Inflammation Laboratory
Uncovered a brand new virus underpinning kidney disease.
Skin Imaging and Inflammation Laboratory
Created a more realistic model of primary liver cancer.
Liver Enzymes in Metabolism and Inflammation Program
Gained new insight into the never-ending arms race between viruses and their hosts.
DNA Repair Laboratory
Determined how to develop safer blood-clotting drugs.
ACRF Centenary Cancer Research Centre
Progressed towards developing a more effective vaccine against tuberculosis.
Uncovered the causes and mechanisms of Alzheimer’s disease.
Lipid Metabolism and Neurochemistry Laboratory
Discovered a cure for a sub-set of one of the most common genetic blood diseases in the world, Beta-thalassemia.
Gene and Stem Cell Therapy Program
Developed a novel drug which is being touted as a major step forward in the battle against obesity.
Lipid Metabolism and Neurochemistry Laboratory
Identified a drug currently used to treat cancer patients as a potential therapy for a leading cause of stroke.
2017
Discovered a new cell in the liver, which will inform future investigations into liver disease and liver cancer.
Revealed evidence of a new target that could be the key to treating liver fibrosis.
Liver Enzymes in Metabolism and Inflammation Program
Discovered that gut bacteria could hold the key to treating and preventing potentially deadly strokes.
Published a world-first study finding that having just one or two energy drinks could be life threatening for some young people with no known history of heart disease.
Identified antibacterial compounds in soil that could lead to new treatments for tuberculosis.
Discovered a common pattern in the process of gene regulation that could be the key to treating and finding cures for cancers and other diseases.
Gene and Stem Cell Therapy Program
Developed a new drug that could be effective in some of the hardest to treat cancers such as pancreatic and liver cancer.
More significant breakthroughs in medical research
2016
Identified a gene essential for stem cell potency.
DNA Repair Laboratory
Further developed our drugs against breast cancer and melanoma.
Discovered a new population of white blood cells in the liver that protects against Malaria.
Discovered evidence that a new blood test we developed is a useful diagnosing liver scarring in patients.
2015
Discovered molecular change driving blood cell development.
Gene and Stem Cell Therapy Program and Bioinformatics
2013
Discovered a new immune cell type that causes skin diseases and skin allergies.
2012
Discovered new drug candidates for prostate and breast cancer.
Origins of Cancer Program
2011
Developed an integrated genetic and clinical approach for early diagnosis and treatment solutions to prevent sudden cardiac death.
Discovery of a new mechanism by which the liver kills immune cells responsible for graft rejection and viral clearance.
2009
Discovered micro RNA can be used to treat diseases associated with vascular leak eg stroke and myocardinal infarction.
2005
Discovered anti TNF therapy increases the risk of reactivation of Tuberculosis.
Improved the identification of human regulatory T Cells, a discovery used widely in clinical research settings.
T Cell Biology Program
1989
Discovered critical insights into the role of the immune system in health and disease.
B Cell Program